Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVNS AVANOS MEDICAL	$12.15 +0.5%	$12.46	$11.84 ▼ $25.36	$561.40M	1.14	375,706 shs	1.07 million shs
LAKE Lakeland Industries	$13.30 +3.8%	$16.87	$12.76 ▼ $27.28	$126.54M	1.13	77,447 shs	528,082 shs
RXST RxSight	$13.61 -1.9%	$14.75	$12.53 ▼ $60.81	$553.07M	1.29	708,226 shs	653,062 shs
SIBN SiBone	$16.39 -1.7%	$16.94	$11.70 ▼ $20.05	$698.46M	0.94	388,707 shs	406,230 shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVNS AVANOS MEDICAL	+0.56%	+0.29%	-4.37%	-17.23%	-36.38%
LAKE Lakeland Industries	+3.83%	-4.45%	-29.26%	-29.10%	-44.70%
RXST RxSight	-1.87%	-4.22%	-14.99%	-45.21%	-76.15%
SIBN SiBone	-1.74%	-5.91%	-14.28%	+11.80%	+32.28%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AVNS AVANOS MEDICAL	2.298 of 5 stars	0.0	3.0	0.0	0.0	2.6	1.7	2.5
LAKE Lakeland Industries	4.9672 of 5 stars	3.5	5.0	0.8	4.9	3.1	3.3	2.5
RXST RxSight	3.0187 of 5 stars	4.2	2.0	0.0	0.0	2.8	1.7	0.6
SIBN SiBone	3.5319 of 5 stars	3.5	2.0	0.0	3.3	0.0	2.5	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVNS AVANOS MEDICAL	0.00	N/A	N/A	N/A
LAKE Lakeland Industries	3.00	Buy	$26.00	95.49% Upside
RXST RxSight	2.30	Hold	$37.90	178.47% Upside
SIBN SiBone	3.00	Buy	$22.50	37.28% Upside

Current Analyst Ratings Breakdown

Latest LAKE, RXST, AVNS, and SIBN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/10/2025	LAKE Lakeland Industries	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$30.00 ➝ $26.00
5/19/2025	RXST RxSight	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Equal Weight ➝ Overweight	$17.00 ➝ $25.00
5/6/2025	SIBN SiBone	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$20.00 ➝ $22.00
5/6/2025	SIBN SiBone	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$25.00 ➝ $25.00
5/6/2025	SIBN SiBone	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$24.00 ➝ $24.00
4/15/2025	LAKE Lakeland Industries	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$28.00 ➝ $23.00
4/15/2025	RXST RxSight	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$18.00
4/9/2025	RXST RxSight	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$45.00 ➝ $16.00
4/4/2025	RXST RxSight	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Underweight	$40.00 ➝ $17.00
4/3/2025	RXST RxSight	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$35.00 ➝ $22.00
4/3/2025	RXST RxSight	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Underperform	$36.00 ➝ $22.00

(Data available from 6/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVNS AVANOS MEDICAL	$687.80M	0.82	$11.91 per share	1.02	$18.03 per share	0.67
LAKE Lakeland Industries	$167.21M	0.76	$1.07 per share	12.46	$15.07 per share	0.88
RXST RxSight	$139.93M	3.95	N/A	N/A	$6.98 per share	1.95
SIBN SiBone	$167.18M	4.18	N/A	N/A	$3.98 per share	4.12

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVNS AVANOS MEDICAL	-$392.10M	-$8.37	N/A	7.02	N/A	-55.80%	6.26%	4.63%	7/30/2025 (Estimated)
LAKE Lakeland Industries	-$18.08M	-$3.01	N/A	8.01	N/A	-13.31%	-6.88%	-4.47%	9/3/2025 (Estimated)
RXST RxSight	-$27.45M	-$0.67	N/A	N/A	N/A	-17.90%	-9.54%	-8.51%	8/4/2025 (Estimated)
SIBN SiBone	-$30.91M	-$0.64	N/A	N/A	N/A	-15.03%	-16.00%	-11.69%	8/4/2025 (Estimated)

Latest LAKE, RXST, AVNS, and SIBN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
6/9/2025	Q1 2026	LAKE Lakeland Industries	$0.27	-$0.41	-$0.68	-$0.41	$48.84 million	$46.75 million
5/7/2025	Q1 2025	RXST RxSight	-$0.03	-$0.03	N/A	-$0.20	$38.74 million	$37.90 million
5/6/2025	Q1 2025	AVNS AVANOS MEDICAL	$0.19	$0.26	+$0.07	$0.14	$161.75 million	$167.50 million
5/5/2025	Q1 2025	SIBN SiBone	-$0.24	-$0.15	+$0.09	-$0.15	$45.13 million	$47.29 million
4/9/2025	Q4 2025	LAKE Lakeland Industries	$0.43	-$0.54	-$0.97	-$2.42	$47.10 million	$46.60 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVNS AVANOS MEDICAL	N/A	N/A	N/A	N/A	N/A
LAKE Lakeland Industries	$0.12	0.90%	N/A	N/A	1 Years
RXST RxSight	N/A	N/A	N/A	N/A	N/A
SIBN SiBone	N/A	N/A	N/A	N/A	N/A

Latest LAKE, RXST, AVNS, and SIBN Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/1/2025	LAKE Lakeland Industries	quarterly	$0.03	0.71%	5/15/2025	5/15/2025	5/22/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVNS AVANOS MEDICAL	0.12	2.57	1.56
LAKE Lakeland Industries	0.17	3.88	1.51
RXST RxSight	N/A	12.68	11.65
SIBN SiBone	0.21	8.53	7.26

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVNS AVANOS MEDICAL	95.17%
LAKE Lakeland Industries	71.69%
RXST RxSight	78.78%
SIBN SiBone	98.11%

Insider Ownership

Company	Insider Ownership
AVNS AVANOS MEDICAL	2.64%
LAKE Lakeland Industries	1.91%
RXST RxSight	9.57%
SIBN SiBone	4.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVNS AVANOS MEDICAL	2,227	46.24 million	45.02 million	Optionable
LAKE Lakeland Industries	2,100	9.51 million	9.33 million	Optionable
RXST RxSight	220	40.64 million	36.75 million	Optionable
SIBN SiBone	350	42.62 million	40.91 million	Optionable

LAKE, RXST, AVNS, and SIBN Headlines

Recent News About These Companies

SI-BONE (NASDAQ:SIBN) Sees Unusually-High Trading Volume - Here's Why

June 13, 2025 | marketbeat.com

Brokers Issue Forecasts for SI-BONE FY2026 Earnings

June 13, 2025 | americanbankingnews.com

Cantor Fitzgerald Weighs in on SI-BONE FY2026 Earnings

June 11, 2025 | marketbeat.com

Harbor Capital Advisors Inc. Sells 308,333 Shares of SI-BONE, Inc. (NASDAQ:SIBN)

June 10, 2025 | marketbeat.com

Charter Oak Capital Management LLC Makes New $337,000 Investment in SI-BONE, Inc. (NASDAQ:SIBN)

June 8, 2025 | marketbeat.com

Insider Selling: SI-BONE, Inc. (NASDAQ:SIBN) Director Sells 3,377 Shares of Stock

June 6, 2025 | marketbeat.com

Two Sigma Investments LP Sells 66,105 Shares of SI-BONE, Inc. (NASDAQ:SIBN)

June 6, 2025 | marketbeat.com

Squarepoint Ops LLC Buys Shares of 32,060 SI-BONE, Inc. (NASDAQ:SIBN)

June 5, 2025 | marketbeat.com

SI-BONE to Truist Securities MedTech Conference on June 17, 2025

June 4, 2025 | globenewswire.com

Wellington Management Group LLP Sells 523,551 Shares of SI-BONE, Inc. (NASDAQ:SIBN)

June 4, 2025 | marketbeat.com

SI-BONE, Inc. (NASDAQ:SIBN) Stock Position Increased by Bank of America Corp DE

June 4, 2025 | marketbeat.com

SI-BONE, Inc. (NASDAQ:SIBN) Shares Sold by Two Sigma Advisers LP

June 1, 2025 | marketbeat.com

15,454 Shares in SI-BONE, Inc. (NASDAQ:SIBN) Bought by Man Group plc

May 29, 2025 | marketbeat.com

SI-BONE to Present at Goldman Sachs 46th Global Healthcare Conference on June 10, 2025

May 28, 2025 | globenewswire.com

SI-BONE’s SWOT analysis: stock poised for growth amid market expansion

May 28, 2025 | investing.com

Wall Street Analysts See a 34.22% Upside in Si-Bone (SIBN): Can the Stock Really Move This High?

May 26, 2025 | zacks.com

Nuveen Asset Management LLC Has $17.72 Million Stake in SI-BONE, Inc. (NASDAQ:SIBN)

May 26, 2025 | marketbeat.com

SI-BONE, Inc. (NASDAQ:SIBN) Shares Bought by Lazard Asset Management LLC

May 23, 2025 | marketbeat.com

Northern Trust Corp Increases Holdings in SI-BONE, Inc. (NASDAQ:SIBN)

May 23, 2025 | marketbeat.com

SI-BONE, Inc. (NASDAQ:SIBN) Shares Acquired by Paradigm Capital Management Inc. NY

May 22, 2025 | marketbeat.com

Virtus Investment Advisers Inc. Acquires Shares of 13,950 SI-BONE, Inc. (NASDAQ:SIBN)

May 21, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

3 Defense Stocks That Will Profit From a Golden Dome
By Chris Markoch | May 30, 2025
View 3 Defense Stocks That Will Profit From a Golden Dome
IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
By Dan Schmidt | June 20, 2025
View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
Analysts Think These Stocks Could More Than Double in Value
By Nathan Reiff | May 23, 2025
View Analysts Think These Stocks Could More Than Double in Value
2 Red-Hot Stocks With High RSIs and More Upside to Come
By Sam Quirke | May 27, 2025
View 2 Red-Hot Stocks With High RSIs and More Upside to Come
Q2’s Most Upgraded Stocks (And No, NVIDIA’s Not on the List)
By Thomas Hughes | June 17, 2025
View Q2’s Most Upgraded Stocks (And No, NVIDIA’s Not on the List)

LAKE, RXST, AVNS, and SIBN Company Descriptions

AVANOS MEDICAL NYSE:AVNS

$12.14 +0.07 (+0.54%)

Closing price 06/20/2025 03:59 PM Eastern

Extended Trading

$12.14 -0.01 (-0.08%)

As of 06/20/2025 04:16 PM Eastern

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Lakeland Industries NASDAQ:LAKE

$13.30 +0.49 (+3.83%)

Closing price 06/20/2025 04:00 PM Eastern

Extended Trading

$13.20 -0.10 (-0.75%)

As of 06/20/2025 07:54 PM Eastern

Lakeland Industries, Inc. manufactures and sells industrial protective clothing and accessories for the industrial and public protective clothing market worldwide. It offers firefighting and heat protective apparel to protect against fire; high-end chemical protective suits to provide protection from highly concentrated, toxic and/or lethal chemicals, and biological toxins; and limited use/disposable protective clothing, such as coveralls, laboratory coats, shirts, pants, hoods, aprons, sleeves, arm guards, caps, and smocks. The company provides durable woven garments, including electrostatic dissipative apparel used in electronics clean rooms; flame resistant meta aramid, para aramid, and FR cotton coveralls/pants/jackets used in petrochemical, refining operations, and electrical utilities; FR fabrics; and cotton and polycotton coveralls, lab coats, pants, and shirts. In addition, it provides high visibility clothing comprising reflective apparel, including vests, T-shirts, sweatshirts, jackets, coats, raingear, jumpsuits, hats, and gloves; and gloves and sleeves that are used in the automotive, glass, and metal fabrication industries. The company sells its products to a network of safety and industrial supply distributors through in-house sales teams, customer service group, and independent sales representatives. It serves end users, such as integrated oil, chemical/petrochemical, automobile, steel, glass, construction, smelting, cleanroom, janitorial, pharmaceutical, and high technology electronics manufacturers, as well as scientific, medical laboratories, and the utilities industry; and federal, state, and local governmental agencies and departments. Lakeland Industries, Inc. was incorporated in 1982 and is headquartered in Huntsville, Alabama.

RxSight NASDAQ:RXST

$13.61 -0.26 (-1.87%)

Closing price 06/20/2025 04:00 PM Eastern

Extended Trading

$13.72 +0.11 (+0.77%)

As of 06/20/2025 06:05 PM Eastern

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

SiBone NASDAQ:SIBN

$16.39 -0.29 (-1.74%)

Closing price 06/20/2025 04:00 PM Eastern

Extended Trading

$16.39 0.00 (-0.03%)

As of 06/20/2025 05:00 PM Eastern

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time